
Therapeutic Use Exemption - application form
Word document - English version
Word document - French version
PDF document - English version
PDF document - French version
Once a year (or more frequently if required), the World Anti-Doping Agency (WADA) issues a list of substances and methods the use of which is prohibited in and/or out of competition. This list is called the “Prohibited List” (available under FIA Anti-Doping Regulations).
However, if, for medical reasons, a driver needs to use a drug including a prohibited substance or a prohibited method (which means that no permitted medicine can be used instead), a request for a “Therapeutic Use Exemption” (TUE) can be made to the competent organisation, whilst ensuring that the deadlines in the regulations are respected.
Complete and detailed documentation explaining the clinical reasons for the therapy requiring the use of a prohibited substance or method must be sent together with the TUE request. It should include the patient’s history, test results, how the disease/disorder/injury has been managed over time, and any and all attempts to use non-prohibited medications and methods.
Who should fill in the TUE?
Your doctor, who must review the medical requirements for the TUE so that he or she can provide all of the relevant information.
When should the TUE form be submitted?
To whom should the application be submitted to?
To the FIA if you are:
- included in the FIA International Registered Testing Pool
- planning to participate in any of the following championships:
– FIA Formula One World Championship,
– FIA World Rally Championship,
– FIA World Touring Car Championship,
– FIA World Endurance Championship,
– CIK-FIA Karting World Championship for Drivers,
– GP2 International Series.
To your National Anti-Doping Organisation:
- in all other cases (for participation both at the national and the international levels)
For more information, please check under FIA Anti-doping Regulations Article 4.5 of Appendix A to the International Sporting Code and the WADA International Standard for Therapeutic Use Exemptions.